IOL Chemicals and Pharmaceuticals Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: IOLCP BSE: 524164

₹205.71

Oct. 5, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #57 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	427,010	143.5	13.7%	7.6%	—	72	8	30
Divi's Laboratories Limited	244,125	83.0	15.3%	57.8%	0.33%	70	4	51
Torrent Pharmaceuticals Limited	161,506	77.7	12.2%	35.3%	0.80%	56	0	31
Zydus Lifesciences Limited	113,616	32.6	17.3%	14.5%	0.09%	74	24	84
Cipla Limited	107,888	35.1	11.2%	-11.7%	0.97%	73	29	62
Laurus Labs Limited	106,505	122.0	17.1%	128.4%	—	78	24	53
Mankind Pharma Limited	102,382	46.9	11.7%	0.9%	—	68	12	86
Dr. Reddy's Laboratories Limited	100,411	150.9	10.9%	-3.7%	—	62	33	71
IOL Chemicals and Pharmaceuticals Limited (this stock)	6,038	35.9	7.7%	98.0%	—	71	26	53

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹6,105 Cr

EV / EBITDA

19.0x

EV / Sales

2.42x

Market cap / Sales

2.39x

Earnings yield

2.79%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 764 Cr, up 36.7% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 64 Cr, up 89.9% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	756	87	64	₹2.2000
March 31, 2026	619	71	53	₹1.8100
Dec. 31, 2025	580	28	21	₹0.7000
Sept. 30, 2025	568	41	30	₹1.0200
June 30, 2025	552	46	34	₹1.1600
March 31, 2025	528	45	32	₹1.0800
Dec. 31, 2024	523	28	21	₹3.5000
Sept. 30, 2024	526	26	19	₹3.2600
June 30, 2024	502	39	30	₹5.0600
March 31, 2024	504	38	28	₹4.8000
Dec. 31, 2023	520	32	23	₹3.9600
Sept. 30, 2023	545	51	38	₹6.4400
June 30, 2023	563	62	46	₹7.8700

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	764	621	586	574	559	532	527	532	510	511	529	552	570
Operating revenue	756	619	580	568	552	528	523	526	502	504	520	545	563
Other income	8	2	5	7	7	5	4	6	7	8	8	7	7
Operating expenses	653	527	523	510	490	465	476	484	452	454	476	481	490
Operating profit	104	93	57	57	62	63	47	42	51	50	44	64	73
Operating profit margin	13.7%	14.9%	9.9%	10.1%	11.3%	11.9%	9.0%	7.9%	10.1%	9.9%	8.5%	11.8%	12.9%
Depreciation	21	20	20	20	20	19	19	18	17	16	16	16	14
Interest	4	3	4	3	4	4	4	4	2	3	4	4	4
Exceptional items, gain / (loss)	—	—	-11	—	—	—	—	—	—	—	—	—	—
Profit before tax	87	71	28	41	46	45	28	26	39	38	32	51	62
Tax	22	18	7	11	12	13	7	7	10	10	9	13	15
Net profit	64	53	21	30	34	32	21	19	30	28	23	38	46
EPS	2.20	1.81	0.70	1.02	1.16	1.08	3.50	3.26	5.06	4.80	3.96	6.44	7.87
Net profit (TTM)	168	138	116	116	105	101	98	100	119	135	172	173	151
EPS (TTM)	5.73	4.69	3.96	6.76	9.00	12.90	16.62	17.08	20.26	23.07	29.38	29.54	25.77

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	2,319	184	138
March 31, 2025	2,079	138	101
March 31, 2024	2,133	183	135
March 31, 2023	2,217	189	140

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	1.4%	3.3%	2,340^†	2,102^†	2,163^†	2,243^†	2,216^†	1,991^†	1,910^†	1,698^†	1,003^†	—
Operating revenue	1.5%	3.3%	2,319	2,079	2,133	2,217	2,184^†	1,967^†	1,894^†	1,685^†	1,001^†	711^†
Other income	—	—	21^†	22^†	30^†	26^†	32^†	24^†	16^†	12^†	2^†	—
Operating expenses	—	—	2,050^†	1,877^†	1,901^†	1,991^†	1,928^†	1,375^†	1,321^†	1,278^†	877^†	558^†
Operating profit	5.9%	-14.6%	269^†	202^†	232^†	227^†	256^†	592^†	574^†	408^†	124^†	153^†
Operating profit margin	—	—	11.6%^†	9.7%^†	10.9%^†	10.2%^†	11.7%^†	30.1%^†	30.3%^†	24.2%^†	12.4%^†	21.5%^†
Depreciation	—	—	80^†	72^†	63^†	46^†	43^†	39^†	36^†	32^†	30^†	30^†
Interest	—	—	15^†	15^†	16^†	16^†	8^†	6^†	21^†	51^†	64^†	67^†
Exceptional items, gain / (loss)	—	—	-11^†	0^†	0^†	0^†	-14^†	0^†	0^†	0^†	0^†	0^†
Profit before tax	-0.9%	-20.2%	184	138	183	189	223^†	571^†	533^†	336^†	31^†	5^†
Tax	—	—	47^†	37^†	47^†	50^†	57^†	127^†	172^†	99^†	4^†	1^†
Net profit	-0.5%	-20.9%	138	101	135	140	166^†	445^†	361^†	237^†	28^†	4^†
EPS	-41.8%	-42.7%	4.69^†	12.90^†	23.07^†	23.84^†	28.22^†	76.21^†	63.51^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	11.6%^†	9.7%^†	10.9%^†	10.2%^†	11.7%^†	30.1%^†	30.3%^†	24.2%^†	12.4%^†	21.5%^†
EBIT margin	8.6%^†	7.3%^†	9.3%^†	9.3%^†	10.6%^†	29.3%^†	29.3%^†	23.0%^†	9.6%^†	10.2%^†
PBT margin	8.0%	6.6%	8.6%	8.5%	10.2%^†	29.0%^†	28.1%^†	19.9%^†	3.1%^†	0.8%^†
Net margin	5.9%	4.9%	6.3%	6.3%	7.6%^†	22.6%^†	19.1%^†	14.0%^†	2.8%^†	0.6%^†
Interest coverage	13.68x^†	10.34x^†	12.34x^†	12.51x^†	27.88x^†	99.01x^†	26.48x^†	7.54x^†	1.49x^†	1.08x^†
Dividend payout	—	—	—	—	—	—	—	—	—	—
Earnings retention	—	—	—	—	—	—	—	—	—	—
Current ratio	1.78x	1.89x	—	—	—	—	—	—	—	—
Quick ratio	1.24x	1.30x	—	—	—	—	—	—	—	—
Debt to equity	0.07x	0.07x	—	—	—	—	—	—	—	—
Return on equity	7.7%	6.0%	—	—	—	—	—	—	—	—
Return on assets	5.3%	4.2%	—	—	—	—	—	—	—	—
Return on capital employed	10.5%^†	8.6%^†	—	—	—	—	—	—	—	—
Asset turnover	0.90x	0.87x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	214	-198	-29	173	41
March 31, 2025	179	-154	46	214	-35
March 31, 2024	291	-192	-92	274	17
March 31, 2023	123	-119	-4	211	-88
March 31, 2022	91	-120	-2	153	-62

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	2,587	1,798	1,740	132	0	1,228	690	65	1,165	371
March 31, 2025	2,382	1,687	1,629	117	0	1,151	610	78	1,158	361
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.